Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys

Establishing how many people have been infected by SARS-CoV-2 remains an urgent priority for controlling the COVID-19 pandemic. Serological tests that identify past infection can be used to estimate cumulative incidence, but the relative accuracy and robustness of various sampling strategies have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Larremore, Daniel B, Fosdick, Bailey K, Bubar, Kate M, Zhang, Sam, Kissler, Stephen M, Metcalf, C Jessica E, Buckee, Caroline O, Grad, Yonatan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Epidemiology and Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979159/
https://www.ncbi.nlm.nih.gov/pubmed/33666169
http://dx.doi.org/10.7554/eLife.64206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979159/
https://www.ncbi.nlm.nih.gov/pubmed/33666169
http://dx.doi.org/10.7554/eLife.64206

Ejemplares similares